Health Technology Assessment in Japan: Policy, Pharmacoeconomic Methods and Guidelines, Value, and Beyond

ISBN-13: 9789811357923 / Angielski / Twarda / 2019 / 259 str.

Isao Kamae

Spis treści

1. Basics to Know.- 2. New HTA Policy in Japan.- 3. MHLW Guideline for Cost-effectiveness Analysis.- 4. How to Appraise.- 5. Exercises for Powerful Assessment.- 6. Intermediate Level Methods.- 7．Advanced Research Topics.

O autorze

Isao Kamae is a professor of HTA project, Graduate School of Public Policy, The University of Tokyo, Japan. He also serves as a research director, The Canon Institute for Global Studies, Tokyo and an advisory expert for WHO and OECD. He has previously worked as an associate professor at Shimane Medical University in 1993-94 and Kyoto University Hospital in 1994-97, a professor, Kobe University School of Medicine in 1997-2007 and Keio University in 2007-2012.

His research interest is primarily in pharmacoeconomics and health technology assessment.

He has published 180 papers and completed work on 31 books. He serves as an editorial board member for Value in Health Regional Issues and Journal of Medical Economics. He has also been awarded ISPOR Distinguished Service Award four times regarding the first Asia-origin ISPOR Board of Director 2004-2006, etc.

Blurb

Representing the first book on the topic, this work offers the reader an introduction to the Japanese systems for health technology assessment (HTA) officially introduced by the Ministry of Health, Labour and Welfare (MHLW) in 2016. Policy and guidelines are discussed, with the relevant methods and conditions of cost-effectiveness analysis explained alongside. Numerous instructive examples and exercises, ranging from basic to advanced, impart valuable knowledge and insight on the quantitative methods for economic evaluation, which will appeal to both beginners and experts.

This guidebook is authored by Japan’s foremost expert in HTA and pharmacoeconomics, with a view to strengthening the reader’s expertise in value-based healthcare and decision-making. The methods presented are essential to informing regulatory, local and patient decisions; as such, the book is equally recommended to industry and government, as well as academia, and anyone with an interest in Japanese HTA.